PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 103 filers reported holding PROMETHEUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $20,288,417 | -67.9% | 189,046 | -67.1% | 0.01% | -66.7% |
Q4 2022 | $63,220,960 | +624.9% | 574,736 | +288.9% | 0.02% | +650.0% |
Q3 2022 | $8,721,000 | -56.9% | 147,800 | -79.4% | 0.00% | -60.0% |
Q2 2022 | $20,251,000 | +2086.9% | 717,403 | +2828.5% | 0.01% | – |
Q1 2022 | $926,000 | -1.9% | 24,497 | -36.3% | 0.00% | – |
Q2 2021 | $944,000 | -7.9% | 38,438 | -31.5% | 0.00% | – |
Q1 2021 | $1,025,000 | – | 56,138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 1,848,024 | $198,329,936 | 93.93% |
CHI Advisors LLC | 934,135 | $100,251,367 | 26.61% |
Cormorant Asset Management, LP | 1,655,000 | $177,615 | 11.70% |
Boxer Capital, LLC | 1,897,500 | $203,640 | 10.00% |
RTW INVESTMENTS, LP | 3,272,104 | $351,162,201 | 7.31% |
Decheng Capital Management III (Cayman), LLC | 150,000 | $16,098,000 | 6.50% |
Waypoint Capital Advisors, LLC | 154,466 | $16,577,292 | 5.40% |
Affinity Asset Advisors, LLC | 150,000 | $16,098,000 | 5.31% |
Perceptive Advisors | 1,272,694 | $136,585,520 | 4.03% |
Ikarian Capital, LLC | 125,926 | $13,514,378 | 3.07% |